Abstract: The present invention related to compounds of formula (I), to pharmaceutical compositions thereof and to their uses, in particular in the treatment and/or prevention of FXR mediated diseases.
Type:
Grant
Filed:
July 17, 2019
Date of Patent:
May 17, 2022
Assignee:
Bar Pharmaceuticals Societa' A Responsabilita' Limitata